Failure of omalizumab (Xolair®) in the treatment of a case of solar urticaria caused by ultraviolet A and visible light

Photodermatology Photoimmunology and Photomedicine

Volumn 27, Issue 6, 2011, Pages 336-337

  Duchini, Giacomo ^a   Bäumler, Wolfgang ^b   Bircher, Andreas J ^a   Scherer, Kathrin ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

Omalizumab; Solar urticaria; Ultraviolet A; Visible light

Indexed keywords

ANTIHISTAMINIC AGENT; DOXEPIN; OMALIZUMAB; SUNSCREEN;

ADULT; ARTICLE; CASE REPORT; CHROMATOPHORE; DRUG TREATMENT FAILURE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRACUTANEOUS TEST; LIGHT; MALE; PHOTOPATCH TEST; PLASMAPHERESIS; PRIORITY JOURNAL; SINGLE DRUG DOSE; SOLAR URTICARIA; SUN EXPOSURE; TREATMENT RESPONSE; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION;

ADULT; ANTI-ALLERGIC AGENTS; ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODIES, MONOCLONAL, HUMANIZED; HUMANS; MALE; PHOTOSENSITIVITY DISORDERS; TREATMENT FAILURE; ULTRAVIOLET RAYS; URTICARIA;

EID: 81355154609     PISSN: 09054383     EISSN: 16000781     Source Type: Journal    
DOI: 10.1111/j.1600-0781.2011.00624.x     Document Type: Article

References (5)

1. Schauder S. Lichturtikaria. Hautarzt 2003; 54: 952-958.
2. Güzelbey O, Ardelean E, Magerl M, Zuberbier T, Maurer M, Metz M. Successful treatment of solar urticaria with antiimmunoglobuline E therapy. Allergy 2008; 63: 1563-1565.
3. Waibel KH, Reese DA, Hamilton RG, Devillez RL. Partial improvement of solar urticaria after omalizumab. J Allergy Clin Immunol 2009; 125: 490-491.
4. Metz M, Altrichter S, Ardelean E etal. Anti-immunoglobulin E treatment of patients with recalcitrant physical urticaria. Int Arch Allergy Immunol 2011; 154: 177-180.
5. Roelandts R. Diagnosis and treatment of solar urticaria. Dermatol Ther 2003; 16: 52-56.